Because the NLRP3 inflammasome may trigger the release of IL-1β after stimulation with various danger signals, it represents a potentially effective target to regulate the onset and development of various autoimmune diseases, such as T1DM. This evidence concerns the gene NLRP3 and autoimmune disease.